Literature DB >> 7620025

Influenza and pneumococcal vaccination in Canada and the United States, 1980-1993: what can the two countries learn from each other?

D S Fedson1.   

Abstract

This study compares influenza and pneumococcal vaccination in Canada and the United States during the period 1980-1993. In Canada, the annual distribution of influenza vaccine during this period increased from 33 to 146 doses per 1,000 population. Provincial health departments purchased 80%-90% of all doses distributed. In the United States, annual distribution of influenza vaccine ranged from 70 to 102 doses per 1,000 population from 1981 to 1990 but increased to 159 doses per 1,000 population over the next 3 years. Throughout the study period, the distribution of pneumococcal vaccine in the United States greatly exceeded that in Canada. Despite similar recommendations regarding the use of these vaccines in the two countries, vaccination practices have differed. In Canada, success with influenza vaccination but not pneumococcal vaccination appears to reflect active public-sector involvement in programs for vaccine purchase and delivery. In the United States, the recent increase in the use of both influenza and pneumococcal vaccines has occurred in the absence of substantial public-sector involvement and may reflect the entrepreneurial nature of American medical practice.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7620025     DOI: 10.1093/clinids/20.5.1371

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  8 in total

1.  Immunization against influenza and pneumococcal disease in residents of long term care facilities.

Authors:  F Aoki
Journal:  Can J Infect Dis       Date:  1996-09

Review 2.  Evaluating the impact of influenza vaccination. A North American perspective.

Authors:  D S Fedson
Journal:  Pharmacoeconomics       Date:  1996       Impact factor: 4.981

Review 3.  Influenza vaccines. A reappraisal of their use.

Authors:  A M Palache
Journal:  Drugs       Date:  1997-12       Impact factor: 9.546

4.  Clinical effectiveness of pneumococcal vaccine. Meta-analysis.

Authors:  B G Hutchison; A D Oxman; H S Shannon; S Lloyd; C A Altmayer; K Thomas
Journal:  Can Fam Physician       Date:  1999-10       Impact factor: 3.275

5.  Invasive Streptococcus pneumoniae infections: serotype distribution and antimicrobial resistance in Canada, 1992-1995.

Authors:  M Lovgren; J S Spika; J A Talbot
Journal:  CMAJ       Date:  1998-02-10       Impact factor: 8.262

6.  Marked reduction in 30-day mortality among elderly patients with community-acquired pneumonia.

Authors:  Gregory W Ruhnke; Marcelo Coca-Perraillon; Barrett T Kitch; David M Cutler
Journal:  Am J Med       Date:  2011-02       Impact factor: 4.965

7.  Prevention of influenza and pneumococcal pneumonia in Canadian long-term care facilities: how are we doing?

Authors:  C G Stevenson; M A McArthur; M Naus; E Abraham; A J McGeer
Journal:  CMAJ       Date:  2001-05-15       Impact factor: 8.262

8.  Household transmission of Streptococcus pneumoniae, Alberta, Canada.

Authors:  J D Kellner; A P Gibb; J Zhang; H R Rabin
Journal:  Emerg Infect Dis       Date:  1999 Jan-Feb       Impact factor: 6.883

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.